News and Events‎ > ‎

A new way of drug screening for Parkinson's disease

posted Apr 17, 2019, 2:05 AM by Mathew Horrocks
We're happy to have contributed to a new method for screening aggregation inhibitors for alpha-Synuclein, the protein associated with Parkinson's disease. The work was done in collaboration with Professor Manfred Auer's group in the School of Biology, and involves growing small protein aggregates on the surface of beads, which can then be imaged and analysed in an automated fashion. The paper was published in Analytical Chemistry.